[go: up one dir, main page]

AR068380A1 - Tratamiento de snc y trastornos del dolor - Google Patents

Tratamiento de snc y trastornos del dolor

Info

Publication number
AR068380A1
AR068380A1 ARP080103887A ARP080103887A AR068380A1 AR 068380 A1 AR068380 A1 AR 068380A1 AR P080103887 A ARP080103887 A AR P080103887A AR P080103887 A ARP080103887 A AR P080103887A AR 068380 A1 AR068380 A1 AR 068380A1
Authority
AR
Argentina
Prior art keywords
pain disorders
disorder
treatment
condition
cns treatment
Prior art date
Application number
ARP080103887A
Other languages
English (en)
Inventor
Vladimir G Granik
Valeryi A Parshin
Irina K Sorokina
Original Assignee
Copharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40084400&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR068380(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Copharm filed Critical Copharm
Publication of AR068380A1 publication Critical patent/AR068380A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Un método para tratar a un paciente que sufre de una condicion o trastorno seleccionado de dolor cronico, dolor neuropático, fibromialgia, migrana, trastorno bipolar y depresion que comprende la administracion de una cantidad farmacologicamente efectiva de 3-(fenilmetilamino-metileno)pirrolidina-2,4-diona (1) o una sal o prodroga o solvato farmacéuticamente aceptable de la misma. También se divulga el uso de (1) para la manufactura de una composicion farmacéutica para el tratamiento de tal condicion o trastorno.
ARP080103887A 2007-09-06 2008-09-05 Tratamiento de snc y trastornos del dolor AR068380A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/851,229 US20090069405A1 (en) 2007-09-06 2007-09-06 Treatment of cns and pain disorders

Publications (1)

Publication Number Publication Date
AR068380A1 true AR068380A1 (es) 2009-11-11

Family

ID=40084400

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080103887A AR068380A1 (es) 2007-09-06 2008-09-05 Tratamiento de snc y trastornos del dolor

Country Status (10)

Country Link
US (1) US20090069405A1 (es)
EP (1) EP2194979B1 (es)
AP (1) AP2779A (es)
AR (1) AR068380A1 (es)
CL (1) CL2008002651A1 (es)
EA (1) EA021199B1 (es)
ES (1) ES2401938T3 (es)
PL (1) PL2194979T3 (es)
TW (1) TW200927095A (es)
WO (1) WO2009031029A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU184787U1 (ru) * 2018-02-27 2018-11-08 Федеральное государственное бюджетное учреждение "33 Центральный научно-исследовательский испытательный институт" Министерства обороны Российской Федерации Стенд для проведения экспериментов по методике "принудительное плавание"

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2144918C1 (ru) * 1997-05-27 2000-01-27 Центр по химии лекарственных средств (ЦХЛС-ВНИХФИ) 3-бензиламинометиленпирролидин-2,4-дион и противосудорожное средство на его основе

Also Published As

Publication number Publication date
EA201000440A1 (ru) 2011-06-30
AP2010005218A0 (en) 2010-01-30
ES2401938T3 (es) 2013-04-25
US20090069405A1 (en) 2009-03-12
CL2008002651A1 (es) 2009-03-20
AP2779A (en) 2013-09-30
PL2194979T3 (pl) 2013-07-31
TW200927095A (en) 2009-07-01
EP2194979B1 (en) 2013-03-13
EP2194979A1 (en) 2010-06-16
WO2009031029A1 (en) 2009-03-12
EA021199B1 (ru) 2015-04-30

Similar Documents

Publication Publication Date Title
LU92642I2 (fr) Pomalidomide et ses sels, solvates, hydrates ou stéréoisomères pharmaceutiquement acceptables qui endérivent (Imnovid)
CO6270360A2 (es) Antagonistas no basicos del receptor de la hormona concentradora de melanina 1 y procedimientos
WO2005046318A3 (en) Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of asbestos-related diseases and disorders
WO2004039320A3 (en) STEREOISOMERS OF p-HYDROXY-MILNACIPRAN, AND METHODS OF USE THEREOF
BRPI0809011A8 (pt) composto, composição farmacêutica, método de tratamento, controle ou prevenção de uma doença ou distúrbio, e, forma de dosagem unitária única
AR119158A1 (es) Tratamientos de angioedema hereditario
CL2011002858A1 (es) Uso de una composicion farmaceutica transmucosa oral que comprende dexmedetomidina y una sal farmaceuticamente aceptable y un excipiente farmaceuticamente aceptable para preparar un medicamento util para tratar o prevenir el dolor.
PE20030347A1 (es) Composiciones farmaceuticas, kits y procedimientos que comprenden combinaciones de agonistas/antagonistas de estrogenos, estrogenos y progestinas
MX2010005342A (es) Compuestos indola y metodos para tratar el dolor visceral.
CL2008000127A1 (es) Compuestos derivados de n-(heteroaril)-1-heteroaril-1h-indol-2-carboxamidas; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del dolor, inflamacion, trastornos urologicos
DK1933833T3 (da) Terapi til behandling af overaktiv blære
MX2010004501A (es) Inhibidor de la proteina de activacion de 5-lipoxigenasa (plap).
EA200870469A1 (ru) Новые, содержащие нимесулид, фармацевтические композиции с низкой дозой, их получение и применение
PE20200741A1 (es) Composiciones farmaceuticas y metodos para tratar enfermedades cardiovasculares
AR119159A1 (es) Tratamientos de angioedema
PH12022550790A1 (en) Oral complement factor d inhibitors
MX2022015629A (es) Uso de vibegron para tratar vejiga sobreactiva.
ECSP066878A (es) [hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il]-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa
PE20241327A1 (es) Tratamiento de trastornos hepaticos con un agonista del thr-beta
MX2024013020A (es) Compuestos de heteroarilo para el tratamiento del dolor
CR20220196A (es) Inhibidores del factor d del complemento para administración oral
SA523440403B1 (ar) Magl مثبط
UY29108A1 (es) Ligandos de difenil éter terapéuticos
GEAP202516634A (en) Heteroaryl compounds for the treatment of pain
AR068380A1 (es) Tratamiento de snc y trastornos del dolor

Legal Events

Date Code Title Description
FB Suspension of granting procedure